Payal Pranami

Payal is an associate scientist, editor development at Verve. Prior to joining Verve, Payal was a senior research associate in the research and development group at Modalis Therapeutics, where she worked on developing therapeutics to treat rare genetic diseases using CRISPR-Cas9 technology. She has diverse expertise in molecular biology, cell culture, screening, and assay development. Payal received her Master of Science in biotechnology from New York University and Bachelor of Engineering in biotechnology from the University of Mumbai.